Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Benjamin

Showing results (871-880 of 920) with videos related to

Pageof 92
Sort By:
Annals of Internal Medicine|May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerS Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Nature Communications|October 13, 2021
Relationship of insect biomass and richness with land use along a climate gradientJohannes Uhler, Sarah Redlich, Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomasJ B Fleming, R S Berman, S C Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033Charles D Blanke, Cathryn Rankin, George D Demetri, et al.
Plos One|September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functionsLei L Chen, Jing Zhu, Jonathan Schumacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progressionLei L Chen, Joseph A Holden, Haesun Choi, et al.
JAMA Oncology|February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.
American Journal of Clinical Oncology|September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2024
Enhanced triplet superconductivity in next-generation ultraclean UTe<sub>2</sub>Z Wu, T I Weinberger, J Chen, et al.
Pageof 92

Showing results (871-880 of 920) with videos related to

Sort By:
Pageof 92
Annals of Internal Medicine|May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerS Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
Nature Communications|October 13, 2021
Relationship of insect biomass and richness with land use along a climate gradientJohannes Uhler, Sarah Redlich, Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomasJ B Fleming, R S Berman, S C Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033Charles D Blanke, Cathryn Rankin, George D Demetri, et al.
Plos One|September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functionsLei L Chen, Jing Zhu, Jonathan Schumacher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progressionLei L Chen, Joseph A Holden, Haesun Choi, et al.
JAMA Oncology|February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.
American Journal of Clinical Oncology|September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2024
Enhanced triplet superconductivity in next-generation ultraclean UTe<sub>2</sub>Z Wu, T I Weinberger, J Chen, et al.
Pageof 92